Shikonin Stimulates Mitochondria‐Mediated Apoptosis by Enhancing Intracellular Reactive Oxygen Species Production and DNA Damage in Oral Cancer Cells
Journal of Cellular Biochemistry · 2025-01 · 126 (1)
DOI: 10.1002/jcb.30671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, 2024-11. Verfasst von Stuti Biswal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Cancer Drug Resistance Laboratory, NIT Rourkela, Rourkela, Odisha, India. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Mouth Neoplasms, Apoptosis, DNA Damage. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: This work was supported by joint CSIR-UGC, New Delhi, India (Grant 997/CSIR-UGC NET JUNE 2019)..
Abstract (Originalsprache)
Phytotherapy has rendered a new insight towards the treatment of various cancers, including oral cancer with fewer side effects, over the traditional chemotherapeutic drugs to overcome chemoresistance. Shikonin (Shk) is a natural biologically active alkaloid found in the Lithospermum erythrorhizon plant's root. It has potent cytotoxic activities against various cancers. Our study revealed the release time and anticancer potential of Shk on the SCC9 and H357 oral cancer cell lines. We investigated the antiproliferative, antimigratory, cell cycle arresting and apoptosis promoting activity of Shk in oral cancer cells by performing MTT and morphological assay, colony, and tumor sphere formation assay, AO/EtBr and DAPI staining, Annexin V‐FITC/PI staining, assay for reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) measurement, comet assay, qRT‐PCR, and western blot analysis. We also checked the interaction of DNA and Shk by docking and CD spectroscopy and EtBr displacement assay. As a result, we found that Shk reduced the viability, proliferation, and tumorigenicity of SCC9 and H357 cells in a time and concentration‐dependent manner. We obtained half‐maximal inhibitory concentration (IC 50 ) at 0.5 µM for SCC9 and 1.25 µM for H357. It promotes apoptosis via overexpressing proapoptotic Bax and caspase 3 via enhancing ROS that leads to MMP depletion and DNA damage and arrests cells at the G2/M & G2/S phase. The antimigratory activity of Shk was performed by analyzing the expression of markers of epithelial–mesenchymal transition like E‐cadherin, ZO‐1, N‐cadherin, and vimentin. These overall results recommended that Shk shows potent anticancer activity against oral cancer cell lines in both in vitro and ex vivo conditions. So, it could be an excellent agent for the treatment of oral cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Science, Cancer Drug Resistance Laboratory, NIT Rourkela, Rourkela, Odisha, India.
Förderung
- This work was supported by joint CSIR-UGC, New Delhi, India (Grant 997/CSIR-UGC NET JUNE 2019).
Zitieren
APA
Biswal, S., Panda, M., & Biswal, B. K. (2025). Shikonin Stimulates Mitochondria‐Mediated Apoptosis by Enhancing Intracellular Reactive Oxygen Species Production and DNA Damage in Oral Cancer Cells. Journal of Cellular Biochemistry, 126(1). https://doi.org/10.1002/jcb.30671
Vancouver
Biswal S, Panda M, Biswal BK. Shikonin Stimulates Mitochondria‐Mediated Apoptosis by Enhancing Intracellular Reactive Oxygen Species Production and DNA Damage in Oral Cancer Cells. Journal of Cellular Biochemistry. 2025;126(1). doi:10.1002/jcb.30671
BibTeX
@article{Biswal2025,
author = {Biswal, Stuti and Panda, Munmun and Biswal, Bijesh Kumar},
title = {Shikonin Stimulates Mitochondria‐Mediated Apoptosis by Enhancing Intracellular Reactive Oxygen Species Production and DNA Damage in Oral Cancer Cells},
journal = {Journal of Cellular Biochemistry},
year = {2025},
volume = {126},
number = {1},
doi = {10.1002/jcb.30671}
}
EUVIMED